| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3360062
Max Phase: Preclinical
Molecular Formula: C19H13NO2S
Molecular Weight: 319.38
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: O=C(Cc1ccc2ccccc2c1)n1sc2ccccc2c1=O
Standard InChI: InChI=1S/C19H13NO2S/c21-18(20-19(22)16-7-3-4-8-17(16)23-20)12-13-9-10-14-5-1-2-6-15(14)11-13/h1-11H,12H2
Standard InChI Key: PAPREHNJYFBQSL-UHFFFAOYSA-N
Associated Targets(Human)
Caspase-7 3146 Activities
Caspase-3 3632 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 319.38 | Molecular Weight (Monoisotopic): 319.0667 | AlogP: 4.10 | #Rotatable Bonds: 2 |
| Polar Surface Area: 39.07 | Molecular Species: | HBA: 4 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 4.17 | CX LogD: 4.17 |
| Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.56 | Np Likeness Score: -0.73 |
References
| 1. Li Z, Pan Y, Zhong W, Zhu Y, Zhao Y, Li L, Liu W, Zhou H, Yang C.. (2014) Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors., 22 (24): [PMID:25468037] [10.1016/j.bmc.2014.11.005] |
Source
Source(1):